Terns Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
TERN
CUSIP
880881107
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 145 83.1 M $230 M
2024 Q4 164 88.1 M $488 M
2024 Q3 169 79.6 M $663 M
2024 Q2 136 66.1 M $450 M
2024 Q1 122 64.8 M $425 M
2023 Q4 114 65.6 M $426 M
2023 Q3 101 61.7 M $310 M
2023 Q2 113 57.7 M $505 M
2023 Q1 80 53.2 M $630 M
2022 Q4 67 49.8 M $507 M
2022 Q3 46 30.3 M $178 M
2022 Q2 43 14.7 M $36.6 M
2022 Q1 45 16.8 M $50.0 M
2021 Q4 38 16.5 M $117 M
2021 Q3 35 16.7 M $174 M
2021 Q2 37 16.6 M $204 M
2021 Q1 43 17.9 M $394 M